Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Early Endosome: Endocytosis of Transferrin

The Early Endosome: Endocytosis of Transferrin

Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...

Blood Transfusion and Agglutination

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

Kidney Transplant III: Nursing Management

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

EHA Recommendations for preconceptual and antenatal screening and prenatal diagnosis for hemoglobinopathies.

HemaSphere·2026

Same author

Phase 2a randomized study to evaluate sapablursen in patients with non-transfusion dependent β-thalassemia intermedia.

Blood advances·2026

Same author

How I manage luspatercept in transfusion-dependent beta-thalassemia.

HemaSphere·2026

Same author

Thalassaemia clinical trials in war-stricken Lebanon: a story of struggle and resilience.

The Lancet. Haematology·2026

Same author

Spirituality and cancer: quality of life, anxiety/depression and symptom severity.

BMJ supportive & palliative care·2025

Same author

Safety and pharmacodynamics of the ferroportin inhibitor vamifeport in patients with non-transfusion-dependent β-thalassemia: results from a randomized phase 2a study.

Orphanet journal of rare diseases·2025

Search research articles

Related Experiment Video

Updated: May 19, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

How I treat transfusional iron overload.

A Victor Hoffbrand¹, Ali Taher, Maria Domenica Cappellini

¹Department of Haematology, University College London and Royal Free Hospital, London, United Kingdom. vhoffbrand@googlemail.com

|August 25, 2012

Summary

This summary is machine-generated.

Magnetic resonance imaging (MRI) and iron chelating drugs improve outcomes for patients with transfusion-dependent anemias like beta-thalassemia major. MRI guides treatment initiation and monitoring for iron overload, enhancing patient survival and quality of life.

More Related Videos

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

Quantifiable and Inexpensive Cell-Free Fluorescent Method to Confirm the Ability of Novel Compounds to Chelate Iron

Quantifiable and Inexpensive Cell-Free Fluorescent Method to Confirm the Ability of Novel Compounds to Chelate Iron

Published on: February 23, 2024

Related Experiment Videos

Last Updated: May 19, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

Quantifiable and Inexpensive Cell-Free Fluorescent Method to Confirm the Ability of Novel Compounds to Chelate Iron

Quantifiable and Inexpensive Cell-Free Fluorescent Method to Confirm the Ability of Novel Compounds to Chelate Iron

Published on: February 23, 2024

Area of Science:

Hematology
Cardiology
Radiology

Background:

Iron overload is a significant complication in patients with beta-thalassemia major and other refractory anemias requiring transfusions.
This iron accumulation can lead to severe organ damage, particularly affecting the heart, liver, and endocrine system.
Recent advancements in MRI and iron chelation therapy have improved patient prognosis.

Purpose of the Study:

To describe the use of MRI (T2*) for assessing cardiac and liver iron in patients with transfusion-dependent anemias.
To guide the initiation and monitoring of iron chelation therapy.
To summarize the properties, efficacy, and side effects of available iron chelating drugs.

Main Methods:

Utilizing magnetic resonance imaging (MRI) T2* sequences to quantify iron levels in the heart and liver.
Reviewing the clinical data and properties of deferoxamine (DFO), deferiprone (DFP), and deferasirox (DFX).
Analyzing treatment strategies including initiation, intensification, drug switching, and combination therapy.

Main Results:

MRI T2* is effective in determining the need for iron chelation therapy and monitoring treatment response.
The three available iron chelating drugs (DFO, DFP, DFX) vary in efficacy, patient acceptability, and side effect profiles.
Management guidelines for initiating, adjusting, or combining chelation therapies have been established.

Conclusions:

MRI-guided iron chelation therapy has significantly improved the prognosis for patients with beta-thalassemia major and other transfusion-dependent anemias.
Optimizing chelation strategies, including the potential of new agents like FBS 0701 and combined oral therapies, can further enhance quality of life and survival.
Accurate monitoring and tailored therapeutic approaches are crucial for managing iron overload in these patients.